Todd Blanche Praised by Pro-Life Groups, Faces Action Calls

According to Mabinty Quarshie writing in Washington Examiner, Blanche informed faith leaders during a White House Faith Office prayer call that he and President Donald Trump were developing a national abortion ban, though implementation was proving slower than anticipated. Audio from the call was briefly posted online by Intercessors for America before being removed.

The Attorney General further stated that the administration sought to make the Supreme Court’s Dobbs v. Jackson Women’s Health Organization ruling, which struck down Roe v. Wade, permanent across all fifty states.

These statements represent some of the most direct assurances from a senior Trump official to anti-abortion activists who have expressed mounting frustration with White House policies on abortion medication and related matters since the President’s return to office.

While Blanche’s comments have drawn approval from pro-life leadership, multiple advocates told Washington Examiner that sustained goodwill depends entirely on whether rhetoric translates into tangible policy changes.

Kristi Hamrick, Vice President of Students for Life of America, whose organization has actively lobbied the Department of Justice on chemical abortion litigation, welcomed the acknowledgment but emphasized concerns remain unaddressed. The Trump Administration has been too quiet on the issues with chemical abortion, she noted, pointing to previous administrations’ roles in approving and deregulating these drugs.

Frank Pavone, head of Priests for Life who was defrocked by the Vatican in 2022, said the Attorney General’s remarks validate confidence within the pro-life movement that the Trump administration will protect the Dobbs victory, ensuring abortion policy remains with the people and their elected representatives.

Abortion rights organizations view Blanche’s confirmation with alarm. Alexis McGill Johnson, president and CEO of Planned Parenthood Action Fund, warned in a statement that the administration and its congressional allies continue attempting to restrict nationwide abortion access and endanger healthcare providers.

Abortion Pills Emerge as Immediate Test

The most pressing challenge for Blanche centers on abortion medication policy.

Anti-abortion groups have consistently urged the administration to limit mifepristone access, particularly mail distribution into states with comprehensive abortion restrictions. Although the Food and Drug Administration launched a study reviewing mifepristone distribution and usage data in June, activists contend the Justice Department already possesses enforcement mechanisms.

Hamrick emphasized that pro-life voters expect returns on their political support, and the DOJ is strategically positioned to address federal chemical abortion pill policies.

Their primary objective involves reversing a Biden administration Justice Department legal opinion permitting abortion drugs including mifepristone and misoprostol to be mailed. Anti-abortion advocates argue this policy violates the 19th-century Comstock Act.

Gavin Oxley, spokesman for Americans United for Life, stated that while Blanche’s assurances are encouraging, they will not halt mail-order abortion independently.

His organization, alongside the Charlotte Lozier Institute, has argued that abortion providers breach FDA Risk Evaluation and Mitigation Strategy regulations for mifepristone by shipping the medication into states with total or near-total abortion prohibitions. They have additionally criticized providers who prescribe mifepristone without thorough patient evaluations.

Oxley insisted Blanche’s confirmation must be followed by complete Comstock Act enforcement, with the DOJ prosecuting abortion providers who violate REMS protocols. He characterized mail-order abortion as a criminal enterprise protected by pro-abortion shield laws that requires DOJ intervention to eliminate.

With information from Washington Examiner